[{"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["ROMPE PECHO MAX MULTI SYMPTOMS"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHOPHAN HBR, PHENYLEPHRINE HCL, GUAIFENESIN"], "manufacturer_name": ["EFFICIENT LABORATORIES INC"], "product_ndc": ["58593-828"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1593450"], "spl_id": ["265921fa-a795-0300-e063-6294a90a6793"], "spl_set_id": ["938e4e47-d2d9-4b0d-bf88-e9f41b501945"], "package_ndc": ["58593-828-08"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "upc": ["000856003095"]}, "product_type": "Drugs", "event_id": "89205", "recalling_firm": "Efficient Laboratories, Inc.", "address_1": "7715 NW 64th St", "address_2": "N/A", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0293-2022", "product_description": "Rompe Pecho Max Multi-Symptoms Maximum Strength, 8 Fl. Oz. (237 mL) bottles, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166 UPC 0 00856 00309 5, NDC 58593-828-08", "product_quantity": "4,026 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20210824", "center_classification_date": "20211222", "termination_date": "20221208", "report_date": "20211229", "code_info": "Lot #: 19G219 Exp. July 2022"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0213-2021", "product_description": "ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe,  SCA Pharmaceuticals 8521 Knoedl Ct., Little Rock, AR, 72205, barcode 70004060409", "product_quantity": "9416 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #    1220023022, BUD 1/17/2021;  1220023023, BUD 1/17/2021;  1220023029, BUD 1/19/2021;  1220023030, BUD 1/20/2021;  1220023117, BUD 1/25/2021;  1220023145, BUD 1/26/2021 &  1220023166, BUD 1/27/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076667"], "brand_name": ["12HR ALLERGY AND CONGESTION RELIEF"], "generic_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "manufacturer_name": ["Cardinal Health"], "product_ndc": ["70000-0518"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["997406"], "spl_id": ["6de2f362-da9d-8ccf-f48c-b72c151d1a0b"], "spl_set_id": ["85e8f580-0b05-81cf-5e0f-f5a176e82766"], "package_ndc": ["70000-0518-1", "70000-0518-2"], "original_packager_product_ndc": ["43598-823"], "unii": ["2S068B75ZU", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "89042", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0272-2022", "product_description": "12 HR Allergy & Congestion Relief Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg Antihistamine I Nasal Decongestant, 20 Extended-Release Tablets USP,  Distributed By Cardinal Health, Dublin, Ohio 43107, Made in India, NDC 70000-0518-1.", "product_quantity": "2496 cartons", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20211112", "center_classification_date": "20211207", "termination_date": "20230623", "report_date": "20211215", "code_info": "Lot #: AC2103329G, Exp 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210708"], "brand_name": ["ELETRIPTAN HYDROBROMIDE"], "generic_name": ["ELETRIPTAN HYDROBROMIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-104", "59651-105"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELETRIPTAN HYDROBROMIDE"], "rxcui": ["359493", "359494"], "spl_id": ["f505017a-a5d7-4f9a-a62f-06a28b30f645"], "spl_set_id": ["bb5ea5df-4add-420d-88cb-6dabe116ca65"], "package_ndc": ["59651-104-06", "59651-104-69", "59651-105-06", "59651-105-69", "59651-105-93"], "is_original_packager": [true], "upc": ["0359651105696"], "unii": ["M41W832TA3"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0438-2021", "product_description": "Eletriptan Hydrobromide Tablets 20 mg* 6(1x6) Unit-dose Tablets Rx only NDC 59651-104-69 Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520", "product_quantity": "20 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EA2020001-A"}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076756"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Nostrum Laboratories Inc."], "product_ndc": ["29033-055", "29033-056"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["34afc382-4296-4212-9bde-babe51e8575d"], "spl_set_id": ["01b1ad34-bee2-461e-b5f5-0b0cf90dfe0b"], "package_ndc": ["29033-055-01", "29033-055-05", "29033-055-10", "29033-056-01", "29033-056-10"], "is_original_packager": [true], "upc": ["0329033056014"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "87210", "recalling_firm": "Nostrum Laboratories Inc", "address_1": "1800 N Topping Ave", "address_2": "", "postal_code": "64120-1228", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0249-2021", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.  NDC: 29033-056-01", "product_quantity": "7071 bottles", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.", "recall_initiation_date": "20210125", "center_classification_date": "20210204", "report_date": "20210210", "code_info": "Lot MET200601, 07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0179-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1229 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1007302021:72 BUD: 01/26/2022; T1005182021:09 BUD: 11/15/2021; T1008112021:73 BUD: 02/07/2022; T1004092021:40 BUD: 10/09/2021; T1006182021:37 BUD: 12/15/2021; T1005242021:71 BUD: 11/20/2021; T1006072021:06 BUD: 12/04/2021; T0606222021:35 BUD: 12/19/2021; T0605112021:23 BUD:11/07/2021 ; T0608162021:19 BUD: 02/12/2022; T1009132021:25 BUD:  03/12/2022; T1004272021:41 BUD: 10/24/2021; T0604152021:26 BUD: 10/12/2021; T1006302021:53 BUD: 12/27/2021; T1008022021:01 BUD: 01/29/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1008042021:66 BUD: 01/31/2022; T1007062021:95 BUD: 01/02/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1006142021:21 BUD: 12/11/2021; T1008042021:66 BUD: 01/31/2022; T1005102021:94 BUD: 11/06/2021; T1007282021:89 BUD: 01/24/2022; T1009222021:75 BUD: 03/21/2022; T1005052021:79 BUD: 11/01/2021; T1008192021:65 BUD: 02/15/2022; T1007132021:14 BUD: 01/09/2022; T1008162021:35 BUD: 02/12/2022; T0607282021:28 BUD: 01/24/2022; T1006022021:06 BUD: 11/29/2021; T1006222021:31 BUD: 12/19/2021; T1004292021:70 BUD: 10/26/2021; T1007212021:82 BUD: 01/17/2022; T1006282021:88 BUD: 12/25/2021; T1004222021:18 BUD: 10/19/2021; T1009082021:11 BUD: 03/07/2022; T1007082021:50 BUD: 01/04/2022; T1009212021:76 BUD: 03/20/2022; T1008312021:01 BUD: 02/27/2022; T0507062021:21 BUD: 01/02/2022; T1004152021:11 BUD: 10/12/2021; T1004192021:50 BUD: 10/16/2021; T1005132021:31 BUD: 11/09/2021; T1008252021:57 BUD: 02/21/2022; T1009152021:06 BUD: 03/14/2022; T1007232021:57 BUD: 01/19/2022; T1006162021:17 BUD: 12/13/2021; T1007122021:16 BUD: 01/08/2022; T1006102021:50 BUD: 12/07/2021; T1005282021:72 BUD: 11/24/2021; T0209082021:89 BUD: 03/08/2022; T0106092021:28 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0604152021:26 BUD: 10/12/2021; T0106092021:53 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0209092021:89 BUD: 03/08/2022; T0109032021:43 BUD: 11/07/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209664"], "brand_name": ["PREGABALIN"], "generic_name": ["PREGABALIN"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-291", "43598-292", "43598-293", "43598-294", "43598-295", "43598-296", "43598-297", "43598-298"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREGABALIN"], "rxcui": ["483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127"], "spl_id": ["4a1e5038-d049-606f-c087-48bc353a8a69"], "spl_set_id": ["ceed457b-8f43-4021-fd70-071c96e09470"], "package_ndc": ["43598-291-90", "43598-291-05", "43598-291-79", "43598-291-66", "43598-291-78", "43598-292-90", "43598-292-05", "43598-292-79", "43598-292-66", "43598-292-78", "43598-293-90", "43598-293-05", "43598-293-79", "43598-293-66", "43598-293-78", "43598-294-90", "43598-294-05", "43598-294-79", "43598-294-66", "43598-294-78", "43598-295-90", "43598-295-05", "43598-295-79", "43598-295-66", "43598-295-78", "43598-296-90", "43598-296-05", "43598-296-79", "43598-296-66", "43598-296-78", "43598-297-90", "43598-297-05", "43598-297-79", "43598-297-66", "43598-297-78", "43598-298-90", "43598-298-05", "43598-298-79", "43598-298-66", "43598-298-78"], "is_original_packager": [true], "unii": ["55JG375S6M"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0469-2021", "product_description": "PREGABALIN CAPSULES 300MG 90 ; NDC 43598-298-90; RX; CAPSULES", "product_quantity": "6 CONTAINERS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "T2000309"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0191-2021", "product_description": "fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004026422", "product_quantity": "1,774 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023275, BUD 2/15/2021; 1220023312, BUD 2/15/2021; 1220023433, 2/22/2021;  1220023515, BUD 2/24/2021 & 1220023671, BUD 3/1/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 120"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-328"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["208545", "1923809"], "spl_id": ["b12c988d-27b2-4548-83c0-a6837ada2db3"], "spl_set_id": ["00046231-8fab-44a0-b986-9a9dd450881d"], "package_ndc": ["42192-328-30", "42192-328-01", "42192-328-07"], "is_original_packager": [true], "upc": ["0342192328013"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0399-2021", "product_description": "NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b) 7-count bottles (NDC 42192-328-07) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 69,289 bottles; b) 9,076 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lot #: a) M328H19-2B, M328J19-11, M328J19-2A, M328J19-3A, M328J19-4A M328J19-5A, M328J19-6A, M328J19-7A, Exp. 08/31/2021, M328K19-2,  M328K19-4A, Exp. 09/30/2021; b) M328J19-9B Exp. 08/31/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0737-2021", "product_description": "Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01", "product_quantity": "434,229 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31325852B, 31325985B, exp. date 10/2021; 31326349B, exp. date 01/2022; 31326873B, exp. date 03/2022; 31326995B, exp. date 05/2022  31327158B, exp. date 06/2022; 31328946B, 31329180B, exp. date 05/2023."}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0677-2021", "product_description": "Goose Creek Hand Sanitizer aloe Dragonfruit Splash, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd., Liberty, KY 42539, UPC 8 18489 01332 5", "product_quantity": "1,296 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20258", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-3410", "68968-3425", "68968-3437", "68968-3450", "68968-3475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632"], "spl_id": ["4d2e5c5f-d82f-4a2c-bfa5-2899fb283696"], "spl_set_id": ["bf185599-2138-4083-9c52-2b95dce09ae0"], "package_ndc": ["68968-3425-8", "68968-3437-8", "68968-3450-8", "68968-3475-8", "68968-3410-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "87741", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0337-2021", "product_description": "Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186  Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8", "product_quantity": "10872 cartons", "reason_for_recall": "Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.", "recall_initiation_date": "20210416", "center_classification_date": "20210420", "termination_date": "20241011", "report_date": "20210428", "code_info": "Lot #: 88321 Exp. 02/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Ridgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87711", "recalling_firm": "Hyobin LLC", "address_1": "455 S Pleasant Ave", "address_2": "N/A", "postal_code": "07450-5413", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0383-2021", "product_description": "Triple SupremeZen Plus 3500, packaged in   cardboard blisters containing one capsule per card, Distributed by Yolo Studio,  Cliffside Park, NJ", "product_quantity": "300 cards", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.", "recall_initiation_date": "20210406", "center_classification_date": "20210514", "report_date": "20210526", "code_info": "all lots"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0133-2022", "product_description": "MIC B12 25/50/50/1+B6 100 MG/ML INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08112021:23 BUD: 11/09/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0673-2021", "product_description": "Goose Creek Hand Sanitizer aloe Limoncello, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL),Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd. Liberty, KY 42539, UPC 8 18489 01333 2", "product_quantity": "1,296 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20258", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0731-2021", "product_description": "Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-0031-01), and b) 5mL Multi Dose Vials (NDC 0703-0043-01), and c) 10 mL Multi-Dose Vials (NDC 0703-0045-01), Rx only, TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "193,845 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: a) 31328455B, exp. date 09/2021; 31329340B, exp. date 12/2021;  31329439B, exp. date 01/2022; 31328347B, exp. date 07/2021  b) 31328321B, exp. date 07/2021; c) 31328368B, 31328394B, exp. date 07/2021; 31328699B, exp. date 09/2021; 31328834B, exp. date 10/2021; 31329286B, exp. date 12/2021"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88594", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0786-2021", "product_description": "Artificial Tears Ointment, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) per tube, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045,  NDC 17478-062-35", "product_quantity": "142,188 tubes", "reason_for_recall": "Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus cereus group.", "recall_initiation_date": "20210802", "center_classification_date": "20210831", "termination_date": "20220822", "report_date": "20210908", "code_info": "Lot #: 9G01A, Exp 06/2022; 9H32A, Exp 07/2022; 9K82A, 9K82B, Exp 09/2022"}, {"status": "Terminated", "city": "Cliffside Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87630", "recalling_firm": "Bit & Bet LLC", "address_1": "25 Oakdene Ave", "address_2": "N/A", "postal_code": "07010-3009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0388-2021", "product_description": "Thumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 617135894673.    Packaged in blister foil sheets in a box. Each box contains 10 capsules.", "product_quantity": "3894 ten-count boxes (38,940 capsules)", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.", "recall_initiation_date": "20210324", "center_classification_date": "20210518", "termination_date": "20210716", "report_date": "20210526", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87545", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0320-2021", "product_description": "Ganirelix Acetate Injection, 250 mcg/0.5 mL, Sterile Prefilled Syringe, Rx only, Distributor: Ferring Pharmaceuticals, Inc., Parsippany, NJ 07054 USA, Manufactured by: Sun Pharmaceutical Industries Ltd, Halol, Gujarat, India Made in India, NDC 55566-1000-1.", "product_quantity": "91,211 syringes", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210315", "center_classification_date": "20210402", "termination_date": "20230606", "report_date": "20210414", "code_info": "Lots JKU1212A, JKU1503A, JKU1504A, JKU1505A, JKU1506A, Exp 03/2021; JKU3313A & JKU3314A, Exp 08/2021."}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0849-2021", "product_description": "Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 50, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), NET WT. 6.5 OZ. (184 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 11254 9", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 30"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-329"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313387", "1724439"], "spl_id": ["0d4e00fa-0373-4c35-9a05-777328f6c41c"], "spl_set_id": ["2eabc9b4-2d5c-44b2-bf05-eb6c3260c1bd"], "package_ndc": ["42192-329-30", "42192-329-01", "42192-329-10", "42192-329-07"], "is_original_packager": [true], "upc": ["0342192329102"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0396-2021", "product_description": "NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192-329-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 113,019 bottles; b) 44,900 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: a) M329D20-1, M329D20-2, M329D20-3 Exp. 03/31/2022, ; b) M329D20-2 Exp. 03/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0493-2021", "product_description": "LEUCOVORIN 15MG 24; NDC/UPC 54449810; RX; TABLETS", "product_quantity": "12 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "064159A"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0058-2022", "product_description": "METHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0836-2021", "product_description": "Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 30,  Avobenzone (3%), Homosalate (8%), Octisalate (5%), Octocrylene (8%), Net Wt. 5.0 OZ (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NY 08858  UPC 0 86800 10038 6", "product_quantity": "1,611,180 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M005"], "brand_name": ["TINACTIN"], "generic_name": ["TOLNAFTATE"], "manufacturer_name": ["Bayer HealthCare LLC"], "product_ndc": ["11523-0165"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TOLNAFTATE"], "rxcui": ["209674", "313421"], "spl_id": ["289de908-7bde-ace6-e063-6294a90a2080"], "spl_set_id": ["bb878f31-2189-4427-aacf-5bce96d75978"], "package_ndc": ["11523-0165-3"], "is_original_packager": [true], "upc": ["0311017410059", "311017410059"], "unii": ["06KB629TKV"]}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0251-2022", "product_description": "Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can,  Labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981,  UPC 3 11017 41005 9, NDC 11523-0165-3.", "product_quantity": "4,990,860 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # (a)TN006MX, EXP 10/31/2022; TN00BKV, TN008D1, TN008D2, EXP 3/31/2023;  (b) CV0180B, EXP12/31/2021; TN003C5, EXP 1/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0015-2022", "product_description": "Coppertone Pure & Simple 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02880 0", "product_quantity": "36,660 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN00BR2, exp. date 03/31/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205209"], "brand_name": ["DARIFENACIN"], "generic_name": ["DARIFENACIN"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-202", "13668-203"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DARIFENACIN HYDROBROMIDE"], "rxcui": ["485421", "485423"], "spl_id": ["bd53ab8c-821a-4a1b-bcda-4fed3bbd6382"], "spl_set_id": ["e84f1ae3-b9a2-4a15-a299-c75373891cc1"], "package_ndc": ["13668-202-30", "13668-202-90", "13668-202-05", "13668-203-30", "13668-203-05", "13668-203-90"], "is_original_packager": [true], "upc": ["0313668203301", "0313668202304"], "unii": ["CR02EYQ8GV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0584-2021", "product_description": "Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only,  Manufactured by: Torrent Pharmaceuticals, LTD Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-203-30", "product_quantity": "37 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BDZ9G005"}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0011-2022", "product_description": "Coppertone Pure & Simple kids 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02882 4", "product_quantity": "167,808 cans", "reason_for_recall": "Chemical contamination; presence of benzene", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN00854, exp. date 01/31/2023 TN00855, exp. date 01/31/2023 TN00CJV, exp. date 06/30/2023"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0046-2022", "product_description": "TEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0207-2021", "product_description": "Sodium Citrate 4% 3 mL Anticoagulation Solution (40mg/mL), Rx only, 3 mL Single Dose Syringe,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004090025", "product_quantity": "5,990 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022961, BUD 1/20/2021; 1220023121, BUD 1/25/2021; 1220023207, BUD 2/12/2021; 1220023363, BUD 2/17/2021 & 1220023526, BUD 2/23/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0456-2021", "product_description": "Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0168-69 Distributed by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "284 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "C80102"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090444"], "brand_name": ["IMIPRAMINE PAMOATE"], "generic_name": ["IMIPRAMINE PAMOATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-314", "68180-315", "68180-316", "68180-317"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IMIPRAMINE PAMOATE"], "rxcui": ["835572", "835577", "835589", "835591"], "spl_id": ["97f2e3f0-0e4b-4b0d-8bfb-53a8a747aea5"], "spl_set_id": ["d1dde497-1889-4424-af18-da7ca6459cf3"], "package_ndc": ["68180-314-06", "68180-314-01", "68180-315-06", "68180-315-01", "68180-316-06", "68180-316-01", "68180-317-06", "68180-317-01"], "is_original_packager": [true], "upc": ["0368180315063", "0368180314066", "0368180316060"], "unii": ["MC34P30298"]}, "product_type": "Drugs", "event_id": "88838", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0027-2022", "product_description": "Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775  India NDC# 68180-316-06", "product_quantity": "1,902 bottles", "reason_for_recall": "Out of specification result observed in a dissolution test at the 9-month long term stability time point.", "recall_initiation_date": "20211008", "center_classification_date": "20211022", "termination_date": "20230313", "report_date": "20211027", "code_info": "lot H002205, exp. date 08/2023"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0323-2021", "product_description": "LCL-2-0191, 5 gallon carboys, Rx only, Manufactured for: LaCore Labs, LLC, by: Washington Homeopathic Products, Inc.260 J R Hawvermale Way Berkeley Springs West Virginia 25411", "product_quantity": "300 liters", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 28506"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0036-2022", "product_description": "DEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Central Islip", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211487"], "brand_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "generic_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-996", "31722-997"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "HYDROCODONE BITARTRATE"], "rxcui": ["856999", "857002"], "spl_id": ["d745e0ac-ee48-44c7-8430-8da0a69d2735"], "spl_set_id": ["ed6af366-753c-4f3b-a6a2-c9a183c50035"], "package_ndc": ["31722-996-01", "31722-996-05", "31722-997-01", "31722-997-05"], "is_original_packager": [true], "upc": ["0331722997010", "0331722996013"], "unii": ["362O9ITL9D", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "89060", "recalling_firm": "Ascent Pharmaceuticals, Inc.", "address_1": "400 S Technology Dr", "address_2": "N/A", "postal_code": "11722-4402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0276-2022", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.", "product_quantity": "9744 bottles", "reason_for_recall": "Product Mix-up", "recall_initiation_date": "20211119", "center_classification_date": "20211207", "termination_date": "20231206", "report_date": "20211215", "code_info": "Lot #: 21070817, Exp 6/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040253"], "brand_name": ["ETHOSUXIMIDE"], "generic_name": ["ETHOSUXIMIDE"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "product_ndc": ["0121-0670"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ETHOSUXIMIDE"], "rxcui": ["251322"], "spl_id": ["14d8b71e-abd8-49d4-b4cc-82880e54db8c"], "spl_set_id": ["8a5cc930-0b36-48a8-9ad0-de633b208742"], "package_ndc": ["0121-0670-16"], "is_original_packager": [true], "upc": ["0301210670169"], "nui": ["N0000175753", "N0000008486"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["5SEH9X1D1D"]}, "product_type": "Drugs", "event_id": "88392", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0723-2021", "product_description": "Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY,  Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16", "product_quantity": "75 cases (6 bottles/case)", "reason_for_recall": "Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.", "recall_initiation_date": "20210729", "center_classification_date": "20210812", "termination_date": "20221202", "report_date": "20210818", "code_info": "Lot: C9BC Exp. 31OCT2022"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0858-2021", "product_description": "ZTE-105 Formula Gentle Detoxing. Contents 1000 mL, RX Only, REMEDY: Bryoni Alba 10X, Chelidonium Majus 10X, Carduus Marianus 10X, Dolichos Pruriens 10X, Solidago Vigaurea 10X, Alfalfa 10X, Boldo 10X, Cynara Scolymus 10X, Zincum Muriaticum 13X, Chromium Sulphuricum 10X, Manganum Metallicum 10X, Dilution Alcohol 20%. WHP Homeopathic Medicine. For Manufacturing Use Only, Manufactured for Optimal Health Dimensi.  Manufactured By: Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "3/1 Liter bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 25950, 26933, Exp 8/17/2026"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0280-2021", "product_description": "Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1995-01.", "product_quantity": "12,609 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326456B, exp. date 02/28/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0277-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA  92618.", "product_quantity": "29,357 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31325042B, exp. date 06/2021  31325336B, exp. date  07/2021  31326042B, exp. date  10/2021  31326137B, exp. date  11/2021  31326230B, exp. date  12/2021  31323816B, exp. date  02/2021"}, {"status": "Ongoing", "city": "Fort Lee", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87641", "recalling_firm": "Nuri Trading LLC", "address_1": "800 Palisade Ave", "address_2": "N/A", "postal_code": "07024-4193", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0685-2021", "product_description": "Shogun-X 7000 capsule, packaged in a) 1-count blister card and b) 10-count box, Nuri Trading LLC", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.", "recall_initiation_date": "20210329", "center_classification_date": "20210719", "report_date": "20210728", "code_info": "all lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0668-2021", "product_description": "SS Eucalyptus Mint Scented Sanitizer, Alcohol Antiseptic 70%, Non-sterile Topical Solution, 3.38 FL. OZ. (100 mL), a) Black and White Collection; b) Photo Real Collection", "product_quantity": "a) 4,248 bottles; b) 3,960 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20248", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205649"], "brand_name": ["XIGDUO"], "generic_name": ["DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-6225", "0310-6270", "0310-6280", "0310-6250", "0310-6260"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DAPAGLIFLOZIN PROPANEDIOL", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1593058", "1593068", "1593070", "1593072", "1593775", "1593831", "1593833", "1593835", "1940496", "1940498"], "spl_id": ["a8717b28-9445-4292-9ac7-e979f378d9c8"], "spl_set_id": ["ac8a0f7b-9f69-4495-abbc-3a47cd75a859"], "package_ndc": ["0310-6270-30", "0310-6270-95", "0310-6280-30", "0310-6280-95", "0310-6250-30", "0310-6250-95", "0310-6260-30", "0310-6260-60", "0310-6260-94", "0310-6260-95", "0310-6225-60", "0310-6225-94"], "is_original_packager": [true], "unii": ["887K2391VH", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0436-2021", "product_description": "xigduo XR (dapagliflozin/metformin HCl extended-release) tablets 5 mg/1000 mg 60 Tablets Rx only NDC 0310-6260-60 Manufactured for: AstraZeneca Pharmaceuticals LP Wilmington, DE 19850", "product_quantity": "378 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "ML0171"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87154", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0232-2021", "product_description": "Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100 per carton (10 capsules x 10 blister cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton: 68084-446-01; NDC Blister Card: 68084- 446-11", "product_quantity": "1948 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210107", "center_classification_date": "20210115", "termination_date": "20220803", "report_date": "20210127", "code_info": "Lot # 193757, Exp 1/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0273-2021", "product_description": "Sterile Diluent for Epoprostenol Sodium for Injection, 50 mL vial (NDC 0703-9258-01), packaged in 2X50ML per tray (NDC 0703-9258-09), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "26,373 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326845B, exp. date 03/2021  Lot # 31327844B, exp. date 09/2021"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87269", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0261-2021", "product_description": "Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety Device For Subcutaneous Injection 10 x 1 mL Single Dose Syringes Rx Only, Manufactured by: Gland Pharma Ltd. Hyderabad, India Manufactured for: Apotex Corp. Weston, FL 33326   NDC 60505-0795-4 UPC 360505079544 (carton) NDC 60505-0795-1 UPC (01)10360505079510 (label)", "product_quantity": "6670 cartons", "reason_for_recall": "Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)", "recall_initiation_date": "20210202", "center_classification_date": "20210217", "report_date": "20210217", "code_info": "Batch: CS008 Exp. 04/2022"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87631", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0331-2021", "product_description": "Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.", "product_quantity": "62,040 tubes", "reason_for_recall": "Failed Stability Specifications: product did not meet viscosity results.", "recall_initiation_date": "20210329", "center_classification_date": "20210412", "termination_date": "20240703", "report_date": "20210421", "code_info": "Lot 13269, Exp March 2021"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88734", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0020-2022", "product_description": "GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only, Manufactured by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.  Carton NDC#: 68084-295-21 (Individual Dose NDC: 68084-295-11)", "product_quantity": "2,266 cartons", "reason_for_recall": "Failed Dissolution Specifications: results were above specification.", "recall_initiation_date": "20210917", "center_classification_date": "20211020", "termination_date": "20230608", "report_date": "20211027", "code_info": "Lot #: 194141, Exp. Date 03/31/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89042", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0271-2022", "product_description": "Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 30 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0638-1242-07.", "product_quantity": "2184 cartons", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20211112", "center_classification_date": "20211207", "termination_date": "20230623", "report_date": "20211215", "code_info": "Lot #: AC2103329D, Exp 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208801"], "brand_name": ["PROGESTERONE"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Dr. Reddys Laboratories, Inc."], "product_ndc": ["43598-349", "43598-350"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROGESTERONE"], "rxcui": ["260243", "312641"], "spl_id": ["4b8f3d16-f096-32f0-65f9-230ab8c292b7"], "spl_set_id": ["efded380-02ff-68c9-13e4-47a561ede440"], "package_ndc": ["43598-349-01", "43598-350-01"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "87411", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0292-2021", "product_description": "Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.", "product_quantity": "16,449 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.", "recall_initiation_date": "20210226", "center_classification_date": "20210303", "termination_date": "20220217", "report_date": "20210310", "code_info": "Batch # 1399851P1, Exp 02/2021", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0216-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 100 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06212021:35 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206763"], "brand_name": ["OLMESARTAN MEDOXOMIL"], "generic_name": ["OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-445", "67877-446", "67877-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLMESARTAN MEDOXOMIL"], "rxcui": ["349373", "349401", "349405"], "spl_id": ["a1d66aa9-d0fa-4d21-bba0-ff8078c2e5af"], "spl_set_id": ["142b735a-e1cd-46e1-a523-3ef061001bf9"], "package_ndc": ["67877-445-30", "67877-445-90", "67877-445-05", "67877-445-10", "67877-446-30", "67877-446-90", "67877-446-05", "67877-446-10", "67877-446-33", "67877-446-84", "67877-446-74", "67877-446-38", "67877-447-30", "67877-447-90", "67877-447-05", "67877-447-10"], "is_original_packager": [true], "upc": ["0367877445304"], "unii": ["6M97XTV3HD"]}, "product_type": "Drugs", "event_id": "87817", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0392-2021", "product_description": "Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.", "product_quantity": "34296 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20230217", "report_date": "20210602", "code_info": "Batch No. 20122548, Exp Date: Aug. 2022"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0113-2022", "product_description": "ESTRADIOL VALERATE 50MG/ML IN ETHYL OLEATE INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "15 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 09162021:29 BUD: 03/15/2022; 09132021:31 BUD: 03/12/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Ciudad De Mexico", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86266", "recalling_firm": "Grupo Asimex de Mexico SA de CV", "address_1": "Mario Pani No 750 Piso 10-C", "address_2": "Col. Santa Fe Cuajimalpa, Cuajimalpa De Morelos", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distributor in FL who further distributed Nationwide in the USA", "recall_number": "D-0795-2021", "product_description": "Florance Morris ANTISEPTIC Hand Sanitizer (ethyl alcohol 70%), packaged in a) 8.45 fl oz (250 mL) bottles and b) 33.81 fl oz (1L) bottles, Distributed by: Asimex International LLC, 9100 S Dadeland Blvd, Ste 912, Miami, FL 33156, COUNTRY OF ORIGIN: MEXICO.", "product_quantity": "22,680 bottles", "reason_for_recall": "Chemical Contamination: FDA analysis found the product contains methanol, additionally it is sub-potent for ethanol content.", "recall_initiation_date": "20200814", "center_classification_date": "20210913", "termination_date": "20231017", "report_date": "20210922", "code_info": "All lots including but not limited to: 200520673 and 200601685", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0202-2021", "product_description": "morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride Injection, (5 mg/mL), Rx Only, 30 mL Single Dose Syringe,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010316", "product_quantity": "50 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023221, BUD 1/31/2021 &  1220023584, BUD 2/9/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0447-2021", "product_description": "DEXAMETH SOD PHOS 0.1% 5ML; NDC/UPC 24208072002; RX; DROPS", "product_quantity": "318 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "353351"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0739-2021", "product_description": "Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0703-1153-03) Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, vial NDC 0703-1153-01", "product_quantity": "34,100 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31329045B, exp. date 07/2021; 31329077B, exp. date 08/2021; 31329312B, exp. date 09/2021"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0834-2021", "product_description": "Neutrogena COOLDRY SPORT sunscreen spray BROAD SPECTRUM SPF 50, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), NET WT 5.0 OZ (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 10036 2", "product_quantity": "867,816 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091623"], "brand_name": ["THIAMINE HYDROCHLORIDE"], "generic_name": ["THIAMINE HYDROCHLORIDE"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-196"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["THIAMINE HYDROCHLORIDE"], "rxcui": ["313324"], "spl_id": ["cbc5513d-4341-455c-b435-53dd5624efaa"], "spl_set_id": ["12986d0e-b8bf-4338-9d85-07f973b35439"], "package_ndc": ["67457-196-00", "67457-196-02"], "is_original_packager": [true], "unii": ["M572600E5P"]}, "product_type": "Drugs", "event_id": "87803", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0601-2021", "product_description": "Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02", "product_quantity": "2,131 cartons", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.", "recall_initiation_date": "20210503", "center_classification_date": "20210601", "termination_date": "20221018", "report_date": "20210609", "code_info": "Lot #: 200906, Exp. Date February 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209482"], "brand_name": ["TRELEGY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0887", "0173-0893"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_id": ["676a0120-5f94-4470-b936-2c8cfb32d3fc"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "package_ndc": ["0173-0887-10", "0173-0887-14", "0173-0887-61", "0173-0893-10", "0173-0893-14", "0173-0893-61"], "is_original_packager": [true], "unii": ["40AHO2C6DG", "7AN603V4JV", "JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0481-2021", "product_description": "TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMEDIDINIUM AND VILANTEROL INHALATION POWDER) 100-62.5-25MCG 60; NDC/UPC 0173-0893-10; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "4065 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "FN2J"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["TINACTIN"], "generic_name": ["TOLNAFTATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-4162"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TOLNAFTATE"], "rxcui": ["705934", "705936"], "spl_id": ["289f4a63-0291-b92a-e063-6394a90a6625"], "spl_set_id": ["5f95be36-6efa-4dfb-9a40-88f4ce1de2b3"], "package_ndc": ["11523-4162-1", "11017-410-00"], "is_original_packager": [true], "upc": ["0311017410004", "311017410004"], "unii": ["06KB629TKV"]}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0242-2022", "product_description": "Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981", "product_quantity": "738,432 cans", "reason_for_recall": "cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # (a) TN004BW, EXP 7/31/2022,   (b) TN00678, EXP 8/31/2022; TN00679, EXP 9/30/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0492-2021", "product_description": "LITHIUM CARB 150MG 100; NDC/UPC 54252625; RX; CAPSULES", "product_quantity": "298 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AB1024A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210705"], "brand_name": ["FENOFIBRATE"], "generic_name": ["FENOFIBRATE"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "product_ndc": ["27241-118", "27241-119", "27241-120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FENOFIBRATE"], "rxcui": ["200311", "310288", "310289"], "spl_id": ["2dffe879-0f18-4961-b1a9-0d69565a04a6"], "spl_set_id": ["da2f0ba4-7c16-4fb0-bc1c-45540e8fefbf"], "package_ndc": ["27241-118-04", "27241-118-05", "27241-119-04", "27241-119-05", "27241-120-04", "27241-120-05"], "is_original_packager": [true], "upc": ["0327241119040", "0327241118043", "0327241120046"], "nui": ["N0000175596", "N0000175375", "M0199111"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "pharm_class_cs": ["PPAR alpha [CS]"], "unii": ["U202363UOS"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0407-2021", "product_description": "FENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULES", "product_quantity": "106 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "PA03410"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "88309", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0750-2021", "product_description": "Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.", "product_quantity": "37560 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification: Some tablets are shaved", "recall_initiation_date": "20210719", "center_classification_date": "20210818", "termination_date": "20221221", "report_date": "20210825", "code_info": "Lot #: T2000471, exp date 09/2023"}, {"status": "Completed", "city": "Morton Grove", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88629", "recalling_firm": "Morton Grove Pharmaceuticals, Inc.", "address_1": "6451 Main St", "address_2": "", "postal_code": "60053-2633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and China", "recall_number": "D-0815-2021", "product_description": "Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate 10 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-606-16", "product_quantity": "14,904 bottles", "reason_for_recall": "CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.", "recall_initiation_date": "20210903", "center_classification_date": "20210920", "report_date": "20210929", "code_info": "Lot #: UV1198", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88370", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0775-2021", "product_description": "Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, NDC 70199-014-01", "product_quantity": "4,587 bottles", "reason_for_recall": "CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC)  for an excipient batch of Dibasic Calcium Phosphate.", "recall_initiation_date": "20210729", "center_classification_date": "20210827", "termination_date": "20221104", "report_date": "20210908", "code_info": "1408822A, exp. date 08/2023 (labeler - Casper)"}, {"status": "Terminated", "city": "Paramount", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87257", "recalling_firm": "DLC Laboratories, Inc", "address_1": "7008 Marcelle St", "address_2": "N/A", "postal_code": "90723-4839", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide and to the following foreign countries: Canada, Cambodia, Germany, and United Kingdom.", "recall_number": "D-0257-2021", "product_description": "Sulfur Ointment 10%, Pomada de Azufre, 2.6 OZ (73.7g) jar; Manufactured by/ Fabricado por: De La Cruz Products, A Division of DLC Laboratories, Inc. Paramount, CA 9023 USA; UPC 024286150426", "product_quantity": "86,297 jars", "reason_for_recall": "Labeling: Label Mix-Up. THe English label with Drug Facts panel for Camphor was incorrectly placed on product.", "recall_initiation_date": "20210106", "center_classification_date": "20210212", "termination_date": "20220923", "report_date": "20210224", "code_info": "Lot # 5084, Exp 05/23; 5130, Exp 07/23; 5132, Exp 07/23; 5160, Exp 08/23."}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0885-2021", "product_description": "ZTE-1034 Formula Antimicrobial Bowel. Contents 1000ml. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Arsenicum Album 10X, Baptisia Tinctoria 10X, Pulsatilla 10X, Lachesis Mutus 11X, Rhus Toxicodendron 10X, Belladonna 7X, Colchicum Autumnale 5X, Aconitum Napellus 8X, Astragalus Menziesli 8X, Carbo Vegetabilis 8X, Chamomilla 3X, Hydrastis Canadensis 3X, Echinacea Angustifolia 12X, Pulsatilla 11X, Anas Barariae, Hepatis ET 60C, Anas Barariae, Hepatis ET 100C,  Anas Barariae, Hepatis ET 200C, Carduus Marianus 6X, Taraxacum Officinale 4X, Berberis Aquifolium 8X, Zingiber Officinal 8X, Allium Sativum 4X, Dilution Alcohol 20%.    Causticum 30X, Conium Maculatum 8X, Conium Maculatum 12X, Crataegus Oxyacantha 12X, Crataegus Oxyacantha 30X, Ignatia Amara 24X, Lycopus Virginicus 12X, Phosphoricum Acidum 12X, Phosphoricum Acidum 24X, Rhus Toxicodendron 24X, Secale Cornutum 24X, Secale Cornutum 30X, Sepia 6X, Sepia 24X, Solanum Nigrum 30X, Zincum Valericanicum 8X, Zincum Valerianicum 12X, Dilution Alcohol 20%.  Manufactured for Optimal Health Dimensions. RX Only. anufactured by Washington Homeopathic Products, Inc. 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "2/1 Liter bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 25887, Exp 8/17/2026"}, {"status": "Terminated", "city": "Bensalem", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206107"], "brand_name": ["ASENAPINE"], "generic_name": ["ASENAPINE"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "product_ndc": ["42794-016", "42794-017"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["ASENAPINE"], "rxcui": ["859975", "859981"], "spl_id": ["f1f1f3b2-6b49-a523-e053-2995a90ad0c9"], "spl_set_id": ["3512687b-d1c7-45c4-8822-3a2ad53575a5"], "package_ndc": ["42794-016-22", "42794-016-08", "42794-016-10", "42794-017-22", "42794-017-08", "42794-017-10"], "is_original_packager": [true], "upc": ["0342794016226", "0342794017100", "0342794016080", "0342794016103", "0342794017087", "0342794017223"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["JKZ19V908O"]}, "product_type": "Drugs", "event_id": "87748", "recalling_firm": "SigmaPharm Laboratories LLC", "address_1": "3375 Progress Dr", "address_2": "N/A", "postal_code": "19020-5801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0379-2021", "product_description": "Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020    NDC 42794-016-10.", "product_quantity": "6266 bottles", "reason_for_recall": "Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent", "recall_initiation_date": "20210419", "center_classification_date": "20210514", "termination_date": "20220926", "report_date": "20210526", "code_info": "Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."], "product_ndc": ["68788-7529"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309113"], "spl_id": ["f170357f-5fe8-4ad4-983a-5e46245070cb"], "spl_set_id": ["6c7bfa58-2d38-4607-8c33-485ba4931c68"], "package_ndc": ["68788-7529-1", "68788-7529-2"], "original_packager_product_ndc": ["67877-545"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87719", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "recalled product was distributed to three physicians located CA", "recall_number": "D-0342-2021", "product_description": "Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,", "product_quantity": "Six bottles", "reason_for_recall": "Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin", "recall_initiation_date": "20210412", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "Lot #: B1121W, Exp.Date: 04/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020870"], "brand_name": ["COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)"], "generic_name": ["ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-0514", "68968-0525"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL", "NORETHINDRONE ACETATE"], "rxcui": ["1251493", "1251495", "1251499", "1251501"], "spl_id": ["a8dddb67-4c56-4d1d-a4ce-83dc426d33f6"], "spl_set_id": ["83198ef1-11c4-11e4-9191-0800200c9a66"], "package_ndc": ["68968-0514-8", "68968-0525-8", "68968-0514-2"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E", "9S44LIC7OJ"]}, "product_type": "Drugs", "event_id": "88342", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0724-2021", "product_description": "Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186", "product_quantity": "223,382 boxes", "reason_for_recall": "Failed Stability Specifications; out of specification for shear.", "recall_initiation_date": "20210730", "center_classification_date": "20210813", "report_date": "20210825", "code_info": "Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0130-2022", "product_description": "MIC B COMPLEX W CHROMIUM/ METHYLCOB (BOYDEN) INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 09022021:50 BUD: 12/01/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0868-2021", "product_description": "Verbena Officinalis 6X, Nervousness* Sucrose/Lactose Pills, Packaged 2 Dram, WHP Homeopathic Medicine, Washington Hoemopathis Producs, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "3 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29060, Exp 8/17/2026"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0247-2022", "product_description": "LOTRIMIN AF, (Miconazole nitrate 2%), Jock Itch, Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain,  NDC 11523-4140-2. UPC 3 11017 41031 8", "product_quantity": "4,546,152 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # CV018TV, 11/30/2021; CV01A71, 1/31/2022; CV01CK4, 4/30/2022; TN0023G, 12/31/2022; TN006TC, 1/31/2023; TN007TG, 3/31/2023; TN008CZ, 4/30/2023; TN008CY, 4/30/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020592"], "brand_name": ["ZYPREXA"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Eli Lilly and Company"], "product_ndc": ["0002-4112", "0002-4115", "0002-4116", "0002-4117", "0002-4415", "0002-4420", "0002-4453", "0002-4454", "0002-4455", "0002-4456", "0002-7597"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["153046", "153047", "153048", "200034", "212405", "261337", "283639", "284514", "312076", "312077", "312078", "312079", "314154", "314155", "351107", "351108", "485968", "545353", "754503", "754504", "754505", "754506"], "spl_id": ["277268c0-c043-47fd-9c20-d4b7f05ef914"], "spl_set_id": ["d5051fbc-846b-4946-82df-341fb1216341"], "package_ndc": ["0002-4112-30", "0002-4115-30", "0002-4116-30", "0002-4117-30", "0002-4415-30", "0002-4420-30", "0002-4453-01", "0002-4453-85", "0002-4454-01", "0002-4454-85", "0002-4455-01", "0002-4455-85", "0002-4456-01", "0002-4456-85", "0002-7597-01"], "is_original_packager": [true], "upc": ["0300024415300", "0300024116306", "0300024115309", "0300024420304", "0300024112308", "0300024117303"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "88193", "recalling_firm": "Eli Lilly & Company", "address_1": "839 S Delaware St", "address_2": "N/A", "postal_code": "46225-1782", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH, MS, IN", "recall_number": "D-0720-2021", "product_description": "Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01", "product_quantity": "36,540 vials", "reason_for_recall": "cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.", "recall_initiation_date": "20210629", "center_classification_date": "20210811", "termination_date": "20230729", "report_date": "20210818", "code_info": "Lot # 197"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87455", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0317-2021", "product_description": "ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 5mg vial, Rx only, ZOMA-Jet 5 Demonstration Kit contains -ZOMA-Jet 5 device - 5 Needle-Free Head A's - 2 Vial Adaptors - 1 Carrying Case - 1 User Manual; Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054; UPC 3 55566 18031 5.", "product_quantity": "301 devices", "reason_for_recall": "Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.", "recall_initiation_date": "20210311", "center_classification_date": "20210330", "termination_date": "20230607", "report_date": "20210407", "code_info": "201601320031  201702320207  201731220039  201817120044  201912720086  201912320044", "more_code_info": ""}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0236-2022", "product_description": "LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3", "product_quantity": "2,817,468 cans", "reason_for_recall": "cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # TN00082, Exp 9/30/2021;TN000TU, TN000TV, Exp. 10/31/2021;  TN00236, Exp. 1/31/2022; TN003C8, Exp 2/28/2022; TN003C9, Exp 3/31/2022; TN003GS, Exp 4/30/2022; TN0041W, Exp 6/30/2022; TN006W8, Exp 8/31/2022; TN005P5, Exp 9/30/2022; TN006MZ, Exp 2/28/2023;", "more_code_info": ""}, {"status": "Terminated", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87608", "recalling_firm": "Cosette Pharmaceuticals, Inc.", "address_1": "111 Coolidge St", "address_2": "N/A", "postal_code": "07080-3801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0327-2021", "product_description": "Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080", "product_quantity": "a) 30 mL: 7724 b) 60 mL: 8064 bottles", "reason_for_recall": "CGMP Deviaitons", "recall_initiation_date": "20210325", "center_classification_date": "20210407", "termination_date": "20230717", "report_date": "20210414", "code_info": "a) 30 mL: 1014611 and 1014612, exp 12/2022    b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88436", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "N/A", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0767-2021", "product_description": "Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903 NDC 70324-326-01", "product_quantity": "1098 bags", "reason_for_recall": "Non-Sterility: firm's third party lab confirmed microbial contamination.", "recall_initiation_date": "20210810", "center_classification_date": "20210825", "termination_date": "20220519", "report_date": "20210901", "code_info": "Lot Number:    BUP, exp. date 03/23/22"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0866-2021", "product_description": "Humulus 6X, 15X, Sucrose/Lactose Pills, 6X Packaged as a) 4dr, UPC 7 40640 33969 5; 15X Packaged as b) 4 dr; WHP Homeopathic Medicine. Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "2 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29298, Exp 8/17/2026"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0170-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.25MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1006092021:18 BUD: 12/06/2021; T1009022021:89 BUD: 03/01/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0406-2021", "product_description": "METHOCARBAMOL 500MG 500; NDC/UPC 71093014005; RX; TABLETS", "product_quantity": "51 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "UMETA0036A"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0841-2021", "product_description": "Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 100, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), Oxybenzone (6%), NET WT. 6.5 OZ (184 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 10144 4", "product_quantity": "876,960 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0188-2021", "product_description": "ePHEDrine Sulfate, 50 mg/5mL in 0.9% Sodium Chloride Injection, 5 mL Single Dose Syringe, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004060509", "product_quantity": "1,879 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023041, BUD 1/20/2021; 1220023188, BUD 1/27/2021 & 1220023397, BUD 2/3/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076667"], "brand_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "generic_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "manufacturer_name": ["RUGBY LABORATORIES"], "product_ndc": ["0536-1242"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["997406"], "spl_id": ["902b8cab-ea03-79e8-668f-36b4edd086be"], "spl_set_id": ["556cf7e5-d177-85c1-9c21-f34e9a8271eb"], "package_ndc": ["0536-1242-34", "0536-1242-07"], "original_packager_product_ndc": ["43598-823"], "unii": ["2S068B75ZU", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "89042", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0270-2022", "product_description": "Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 20 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0536-1242-34.", "product_quantity": "2352 cartons", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20211112", "center_classification_date": "20211207", "termination_date": "20230623", "report_date": "20211215", "code_info": "Lot #: AC2103329H, Exp 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0190-2021", "product_description": "Esmolol HCl 100 mg/10 mL (10mg/ mL), 10 mL Single Dose Syringe,  Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd.,  Windsor, CT, 06095, barcode 70004062012", "product_quantity": "952 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023042, BUD 1/21/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0515-2021", "product_description": "VITAMIN D3 25MCG 90 TABLETS; NDC/UPC 880681168004; OTC; TABLETS", "product_quantity": "53 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0097-2022", "product_description": "Estradiol Valerate 20 mg/mL in Ethyl Oleate Inj. 20 mg/mL Injection in vials, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "335 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 04122021:51 BUD: 10/09/2021; 04232021:94 BUD: 10/20/2021; 05032021:52 BUD: 10/30/2021; 05242021:73 BUD: 11/20/2021; 05172021:47 BUD: 11/13/2021; 06302021:93 BUD: 12/27/2021; 06222021:98 BUD: 12/19/2021; 06072021:83 BUD: 12/04/2021; 07152021:86 BUD: 01/11/2022; 07222021:52 BUD: 01/18/2022; 08062021:11 BUD: 02/02/2022; 08192021:73 BUD: 02/15/2022; 08312021:22 BUD: 02/27/2022; 09162021:58 03/15/2022; 09082021:15 BUD: 03/07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0136-2022", "product_description": "QUAD-MIX PAPAV 30/PHENTOL 1/PGE-1 10/ATROPINE 0.15 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07072021:20 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Ridgefield Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87613", "recalling_firm": "S & B Story LLC", "address_1": "30 Railroad Ave", "address_2": "N/A", "postal_code": "07660-1347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0352-2021", "product_description": "Imperial Extreme 2000 Capsules, 2000 mg, 1 count blister cards, distributed S&B Shopper LLC. Little Ferry, NJ UPC 7 18122 04073 5", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.", "recall_initiation_date": "20210325", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "all lots and expirys", "more_code_info": ""}, {"country": "United States", "city": "Simpsonville", "address_1": "1071 Holland Rd Ste 2", "reason_for_recall": "Labeling: Incorrect Exp. Date: Incorrect BUD.", "address_2": "", "product_quantity": "109 syringes", "code_info": "Lots: K10521042 and K20521043 Exp. 08/31/2021.", "center_classification_date": "20210702", "distribution_pattern": "Distributed in South Carolina", "state": "SC", "product_description": "Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, Compounded by Prisma Health Outsourcing Facility 1071 Holland Rd. Suite 2 Simpsonville, SC 29681.  NDC: 73463-0100-01", "report_date": "20210623", "classification": "Class III", "openfda": {}, "recalling_firm": "Prisma Health Outsourcing Facility", "recall_number": "D-0648-2021", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "88097", "termination_date": "20210921", "more_code_info": "", "recall_initiation_date": "20210608", "postal_code": "29681-5709", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0014-2022", "product_description": "Coppertone SPORT Sunscreen Spray 50, (To Deliver) Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%, NET WT 1.6 OZ (45 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 41100 00506 9", "product_quantity": "143,376 cans", "reason_for_recall": "Chemical contamination; presence of benzene", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN00BU3, exp. date 05/31/2024"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065129"], "brand_name": ["CEFIXIME"], "generic_name": ["CEFIXIME"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-405", "68180-407", "68180-416", "68180-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFIXIME"], "rxcui": ["309058", "409823", "419849"], "spl_id": ["735f86f4-369c-4f5a-adbe-7dacea2e27b4"], "spl_set_id": ["6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"], "package_ndc": ["68180-405-01", "68180-407-03", "68180-407-04", "68180-416-08", "68180-416-11", "68180-423-11", "68180-423-08"], "is_original_packager": [true], "upc": ["0368180423089", "0368180407034", "0368180416081", "0368180416111"], "unii": ["97I1C92E55"]}, "product_type": "Drugs", "event_id": "87871", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0390-2021", "product_description": "Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01", "product_quantity": "3,138 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210519", "termination_date": "20220222", "report_date": "20210526", "code_info": "Lot #: F900787, Exp. Date 4/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0374-2021", "product_description": "Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg/mL), Rx Only, FOR IM or IV Use, Sterile, Teva Parenteral Medicines, Inc., Irvine, CA  NDC 0703-5145-01; ALSO LABELED UNDER: NOVAPLUS, Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-5145-91 (Novaplus, a registered trademark of Vizient, Inc.)", "product_quantity": "192,277 cartons/1 single dose vial per carton", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "NDC 0703-5145-01: Lot # 31325332B, exp. date 08/2021, Lot # 31325756B, exp. date 09/2021 AND NDC 0703-5145-91: Lot # 31325685B, exp. date 09/2021"}, {"status": "Terminated", "city": "Cambridge", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87256", "recalling_firm": "Akebia Therapeutics dba Keryx Biopharmaceutials, Inc", "address_1": "245 1st St", "address_2": "N/A", "postal_code": "02142-1200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0260-2021", "product_description": "Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.", "product_quantity": "17,664 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210129", "center_classification_date": "20210217", "termination_date": "20220210", "report_date": "20210224", "code_info": "Lots #: CDKSN, CDPPH, Exp January 2022;  Lot #: CDPPK, Exp February 2022."}, {"status": "Terminated", "city": "Horseheads", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87500", "recalling_firm": "X-Gen Pharmaceuticals Inc.", "address_1": "300 Daniel Zenker Dr", "address_2": "N/A", "postal_code": "14845-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0328-2021", "product_description": "Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets,  Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5", "product_quantity": "720  100-count (10x10 blister strips)", "reason_for_recall": "Failed Stability Specifications:  Out of Specification (OOS) result reported for microbiological assay", "recall_initiation_date": "20210319", "center_classification_date": "20210408", "termination_date": "20221207", "report_date": "20210414", "code_info": "Lot # CFMBX, EXP 9/2022"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090162"], "brand_name": ["TOPIRAMATE"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-115", "29300-116", "29300-117", "29300-118"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_id": ["b609e53c-2d69-4437-b2a1-9f322208eb27"], "spl_set_id": ["6ee00e82-799d-445e-b658-a9712c49a28e"], "package_ndc": ["29300-115-16", "29300-115-01", "29300-115-05", "29300-115-10", "29300-116-16", "29300-116-01", "29300-116-05", "29300-116-10", "29300-117-16", "29300-117-01", "29300-117-05", "29300-117-10", "29300-118-16", "29300-118-01", "29300-118-05", "29300-118-10"], "is_original_packager": [true], "upc": ["0329300118162"], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "88891", "recalling_firm": "UNICHEM PHARMACEUTICALS USA INC", "address_1": "1 Tower Center Blvd Ste 2200", "address_2": "", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0255-2022", "product_description": "Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India.  Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.", "product_quantity": "1284 bottles", "reason_for_recall": "Discoloration", "recall_initiation_date": "20211025", "center_classification_date": "20211119", "termination_date": "20221012", "report_date": "20211201", "code_info": "Lot #: ZTPM20044, Exp. Date 09/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077651"], "brand_name": ["ZONISAMIDE"], "generic_name": ["ZONISAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-128", "68462-129", "68462-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZONISAMIDE"], "rxcui": ["314285", "403966", "403967"], "spl_id": ["c00ccc2d-52c6-4a11-a310-d8db25ca3928"], "spl_set_id": ["fe15e56e-8b86-4a65-825c-31d37dd81612"], "package_ndc": ["68462-128-01", "68462-128-05", "68462-129-01", "68462-129-05", "68462-130-01", "68462-130-05"], "is_original_packager": [true], "upc": ["0368462130018", "0368462129012", "0368462128015"], "nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["459384H98V"]}, "product_type": "Drugs", "event_id": "88591", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0825-2021", "product_description": "Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430", "product_quantity": "15936 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210827", "center_classification_date": "20210921", "termination_date": "20231004", "report_date": "20210929", "code_info": "Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202870"], "brand_name": ["METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE"], "generic_name": ["METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-115", "62332-116", "62332-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "METOPROLOL TARTRATE"], "rxcui": ["866479", "866482", "866491"], "spl_id": ["10e75c6b-f79e-4424-b4c1-0ea73a98c64d"], "spl_set_id": ["2b77f66f-6891-4977-be8f-7955473d2f92"], "package_ndc": ["62332-115-30", "62332-115-31", "62332-115-91", "62332-116-30", "62332-116-31", "62332-116-71", "62332-117-30", "62332-117-31", "62332-117-71", "2005005745"], "is_original_packager": [true], "upc": ["0362332115303"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0412-2021", "product_description": "Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA", "product_quantity": "71 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2005005745"}, {"status": "Terminated", "city": "Woodcliff Lake", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88326", "recalling_firm": "Professional Disposables International, Inc", "address_1": "400 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "07677-7604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0764-2021", "product_description": "PDI Duo-Swab Povidone-Iodine Cleansing Scrub Swabstick, (1's), Step 1, packaged as a) Step 1 Scrub, 1 Swabstick,  NDC 10819-3891-1,  b) Step 2 Prep, 1 Swabstick, NDC 10819-3890-1, Professional Disposable International, Inc., Orangeburg, NY 10962 -1376 Reorder No S23125, UPC (01)00318019000161", "product_quantity": "11,039 cases", "reason_for_recall": "SubPotent: Out of Specification", "recall_initiation_date": "20210723", "center_classification_date": "20210820", "termination_date": "20230531", "report_date": "20210901", "code_info": "SKU S23125 Lot #'s 11900971, 11901517, 11901756, 12000199, 12000286, 12000459, 12000686, 12000751, 12001009, 12001316, 12001795, 12001809, 12001862, 12001863, 12002140, 12002141, 12100392 and 12100393"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0210-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 5 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08042021:56 BUD: 11/30/2021", "more_code_info": ""}]